Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950135-08-003240
Filing Date
2008-05-01
Accepted
2008-05-01 16:59:10
Documents
1
Group Members
PETER KOLCHINSKYRA CAPITAL BIOTECH FUND II, L.P.RA CAPITAL BIOTECH FUND, L.P.RICHARD H. ALDRICH

Document Format Files

Seq Description Document Type Size
1 GENELABS TECHNOLOGIES, INC.. b69974rasc13g.htm SC 13G 84637
  Complete submission text file 0000950135-08-003240.txt   86657
Mailing Address 505 PENOBSCOT DR REDWOOD CITY CA 94063
Business Address 505 PENOBSCOT DR REDWOOD CITY CA 94063 6503969500
GENELABS TECHNOLOGIES INC /CA (Subject) CIK: 0000874443 (see all company filings)

EIN.: 943010150 | State of Incorp.: CA | Fiscal Year End: 0131
Type: SC 13G | Act: 34 | File No.: 005-42078 | Film No.: 08795448
SIC: 2834 Pharmaceutical Preparations

Mailing Address 111 HUNTINGTON AVE, SUITE 610 BOSTON MA 02199
Business Address 111 HUNTINGTON AVE, SUITE 610 BOSTON MA 02199 617-778-2512
RA CAPITAL MANAGEMENT, LLC (Filed by) CIK: 0001346824 (see all company filings)

EIN.: 830406777 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G